NASDAQ:LFST

LifeStance Health Group (LFST) Stock Price, News & Analysis

LifeStance Health Group logo
$13.81 +0.47 (+3.52%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$13.63 -0.18 (-1.33%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About LifeStance Health Group Stock (NASDAQ:LFST)

Advanced

Key Stats

Today's Range
$13.21
▼
$13.83
50-Day Range
$11.74
▼
$14.60
52-Week Range
$6.09
▼
$15.66
Volume
5.62 million shs
Average Volume
6.65 million shs
Market Capitalization
$5.25 billion
P/E Ratio
72.69
Dividend Yield
N/A
Price Target
$14.86
Consensus Rating
Moderate Buy

Company Overview

LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals.

Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders.

Founded in 2017, LifeStance has expanded its network across the United States. Its care is delivered by professionals such as psychiatrists, psychologists, therapists and other licensed clinicians.

AI Generated. May Contain Errors.

LifeStance Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

LFST MarketRank™: 
3.348170816525 of 5 stars

LifeStance Health Group scored higher than 67% of companies evaluated by MarketBeat, and ranked 187th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 1 strong buy rating, 5 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for LifeStance Health Group is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    LifeStance Health Group has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about LifeStance Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeStance Health Group are expected to grow by 35.00% in the coming year, from $0.20 to $0.27 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeStance Health Group is 72.69, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.26.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeStance Health Group is 72.69, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.53.

  • Price to Book Value per Share Ratio

    LifeStance Health Group has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.71% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 4.37.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently decreased by 0.76%, indicating that investor sentiment is improving.
  • Dividend Yield

    LifeStance Health Group does not currently pay a dividend.

  • Dividend Growth

    LifeStance Health Group does not have a long track record of dividend growth.

  • News Sentiment

    LifeStance Health Group has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for LifeStance Health Group this week, compared to 4 articles on an average week.
  • Search Interest

    7 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $41,646,338.00 in company stock.

  • Percentage Held by Insiders

    3.50% of the stock of LifeStance Health Group is held by insiders.

  • Percentage Held by Institutions

    85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LifeStance Health Group's insider trading history.
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFST Stock News Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
See More Headlines

LFST Stock Analysis - Frequently Asked Questions

LifeStance Health Group's stock was trading at $7.04 at the beginning of the year. Since then, LFST shares have increased by 96.2% and is now trading at $13.81.

LifeStance Health Group, Inc. (NASDAQ:LFST) issued its quarterly earnings data on Thursday, November, 5th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. The business's revenue was up 25.3% compared to the same quarter last year.
Read the conference call transcript
.

LifeStance Health Group's board initiated a stock repurchase program on Wednesday, February 25th 2026, which allows the company to repurchase $100 million in outstanding shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

LifeStance Health Group (LFST) raised $640 million in an IPO on Wednesday, June 9th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

LifeStance Health Group's top institutional shareholders include Summit Partners L P (4.35%), Marshall Wace LLP (2.62%), State Street Corp (2.60%) and Voya Investment Management LLC (1.04%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Kevin Michael Mullins, Eric Shuey, Robert Bessler, Ryan Pardo, Danish J Qureshi, David Bourdon, Ann Varanakis, Lisa K Miller, Paula Cipollone, Vukasin Paunovich and Ujjwal Ramtekkar.
View institutional ownership trends
.

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include SoFi Technologies (SOFI), Micron Technology (MU), Advanced Micro Devices (AMD), PayPal (PYPL), ARM (ARM), DLocal (DLO) and monday.com (MNDY).

Company Calendar

Last Earnings
11/05/2026
Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:LFST
CIK
1845257
Fax
N/A
Employees
10,961
Year Founded
2017

Price Target and Rating

High Price Target
$20.00
Low Price Target
$9.00
Potential Upside/Downside
+7.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.19
Trailing P/E Ratio
72.69
Forward P/E Ratio
51.15
P/E Growth
N/A
Net Income
$9.66 million
Net Margins
4.29%
Pretax Margin
5.36%
Return on Equity
4.82%
Return on Assets
3.30%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
1.44
Quick Ratio
1.44

Sales & Book Value

Annual Sales
$1.42 billion
Price / Sales
3.69
Cash Flow
$0.16 per share
Price / Cash Flow
86.08
Book Value
$3.93 per share
Price / Book
3.51

Miscellaneous

Outstanding Shares
380,190,000
Free Float
366,884,000
Market Cap
$5.25 billion
Optionable
Optionable
Beta
1.35

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:LFST) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners